Loading candles…
Anuh Pharma Ltd, incorporated in 1960, operates primarily in the pharmaceuticals and chemicals industries. The company manufactures and sells bulk drugs and chemicals, with a particular focus on Active Pharmaceutical Ingredients (APIs) and related pharmaceutical products. Its business segments include Active Pharmaceutical Ingredients manufacturing, pharmaceutical formulations, trading, and logistics. Anuh Pharma holds a significant market position in Macrolides and Anti-TB products and is recognized as one of India's largest manufacturers in these categories. It offers a range of products such as bulk drugs, chemicals, Macrolides, Anti-TB, Anti-bacterial, Anti-malarial, Anti-hypertension, and Corticosteroid medicines. The company operates across multiple geographies including India, Europe, Africa, Asia, and the Americas, exporting to over 59 countries worldwide, with exports accounting for about 55% of its total revenue in FY25. Anuh Pharma is a member of the SK Group and is listed on the exchange under the symbol ANUHPHR.
This page is a live market overview for ANUH PHARMA LIMITED (ANUHPHR) on the NSE. As a listed security, ANUH PHARMA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ANUHPHR before placing trades on tick2trade.
As of the latest feed, ANUHPHR last traded at ₹79.32 on NSE, up ₹0.01 (0.01%) from the previous close of ₹79.31. Today's session range is ₹78.37 – ₹81.74, against a 52-week band of ₹67 – ₹95.79. Traded volume today stands at 1.03L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ANUHPHR in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ANUHPHR is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ANUH PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ANUHPHR. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ANUHPHR option chain page linked from this overview.
| Date |
|---|
| Unaudited Results - FY26 | To consider and approve the Unaudited financial results for the period ended Jun 30, 2026 and other business matters. | 7 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 20 May 2026 |
| Unaudited Results - Q3-FY25 | ANUH PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 06 Feb 2026 to consider and approve the quarterly Unaudited Financial results… | 6 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Un-Audited financial results for the Quarter and Half Year ended September 30, 2025 and other business matters | 7 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the Quarterly Unaudited financial results of the Company for the period ended Jun 30, 2025 and other business matters | 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend, bonus and other business matters | 23 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.